Lyvgen Biopharma is a Healthcare Company.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 23, 2021 | Series C | $10M | 1 | — | — | Detail |
| Jul 18, 2018 | Series B | $30M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Longmen Capital
|
— | Series C |
|
|
— | Series B |